VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Position in LifeStance Health Group, Inc. $LFST

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 139,500 shares of the company’s stock, valued at approximately $721,000.

Several other institutional investors also recently bought and sold shares of the stock. TD Asset Management Inc purchased a new stake in shares of LifeStance Health Group in the second quarter valued at approximately $780,000. Blair William & Co. IL purchased a new stake in shares of LifeStance Health Group in the second quarter valued at approximately $70,000. Public Employees Retirement System of Ohio purchased a new stake in shares of LifeStance Health Group in the second quarter valued at approximately $70,000. Park Edge Advisors LLC purchased a new stake in shares of LifeStance Health Group in the second quarter valued at approximately $52,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of LifeStance Health Group by 1.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock valued at $4,100,000 after buying an additional 11,331 shares in the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. UBS Group boosted their price objective on LifeStance Health Group from $8.50 to $9.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Weiss Ratings restated a “sell (e+)” rating on shares of LifeStance Health Group in a research report on Wednesday, October 8th. Wall Street Zen cut LifeStance Health Group from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. BTIG Research began coverage on LifeStance Health Group in a research report on Friday, July 25th. They issued a “buy” rating and a $8.00 price objective for the company. Finally, Zacks Research upgraded LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

LifeStance Health Group Stock Up 1.2%

Shares of LFST opened at $5.20 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. LifeStance Health Group, Inc. has a one year low of $3.74 and a one year high of $8.61. The stock has a market capitalization of $2.02 billion, a price-to-earnings ratio of -104.00 and a beta of 1.17. The stock has a 50 day moving average price of $5.35 and a 200 day moving average price of $5.39.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The firm had revenue of $345.31 million during the quarter, compared to analysts’ expectations of $345.05 million. During the same period in the previous year, the business earned ($0.06) earnings per share. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts forecast that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other LifeStance Health Group news, Director Darren M. Black sold 8,407,643 shares of the business’s stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the transaction, the director owned 33,524,715 shares of the company’s stock, valued at approximately $169,970,305.05. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the business’s stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $18,213,249.99. Following the transaction, the insider directly owned 14,324,197 shares in the company, valued at $72,623,678.79. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,407,643 shares of company stock valued at $103,466,750. Insiders own 3.20% of the company’s stock.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.